coming off glp-1 GLP-1: Does the Magic End? What Happens When You Stop
Description
A one-year course of semaglutide partially reversed WR, suggesting a potential adjunctive role for GLP-1 agonists in selected patients
Doses of liraglutide previously shown to have efficacy in AD and PD mouse models were used
We used version 2 of the Cochrane risk-of-bias tool for randomised trials to assess risk of bias for the primary outcome
GLP-1 Diet Tips Page (includes practical guidance on diet practices and eating habits)
Nicotine has rewarding effects that motivate its consumption
